Latest Lodging News

Estrella Resources has expanded its Timor-Leste exploration footprint by 100km2 while securing conditional approval to export a 100-tonne manganese sample to an Indonesian customer. The company is also preparing 3,000 metres of drilling and a possible upgrade to part of its 621Mt Werumata limestone resource.

AnteoTech expects to increase its unaudited FY2026 loss to $5.38 million after revising the accounting treatment of a lease make-good provision. The adjustment is non-cash, leaving cash and cash flows unchanged, but the audit is still incomplete and the figures may change again.

PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.

OD6 Metals has submitted a Plan of Operations covering up to 139 drill pads and bulk sampling at its Quinn Fluorspar Project in Nevada. The application moves the project towards its first systematic drilling campaign, but approval from the U.S. Forest Service remains outstanding.

Key Petroleum has received the funds and issued 3.38 million shares under its additional placement capacity, raising AU$247,052.88 before costs. The capital is earmarked for potential asset acquisitions, existing asset development and working capital.

A2MP Investments says it now controls 56.63% of Canyon Resources’ voting power, yet its takeover offer remains subject to two unresolved conditions. The notice does not confirm that the bid has succeeded or that the conditions will be waived.

Vaughan Nelson Global Equity SMID Fund delivered a sharp rise in operating profit and more than quadrupled its net assets in FY2026, helped by $31.8 million in investment gains and strong investor applications. The result also leaves the ASX-listed Class B units with greater exposure to global equity and currency movements.

Talisman Mining has issued 47 million new shares as the first tranche of its previously announced placement, but the filing does not disclose the issue price or resulting dilution. A section 708A notice confirms the shares were issued without a prospectus or other disclosure document.

Bubs Australia has secured permanent US FDA authorisation for three infant formula products, removing a regulatory barrier in the company’s largest market. The approval supports possible portfolio expansion and contract manufacturing, but the presentation contains no new earnings guidance or quantified financial benefit.

Tungsten Mining has secured the primary approvals needed to take its Watershed tungsten project in Far North Queensland through to mining and production, while early site works are already under way. The project remains pre-FID, with financing and the October DFS still critical to the H1 2027 production target.

Fat Prophets Global Contrarian Fund will pay an unfranked final dividend of 3 cents per share after what it describes as strong investment performance. Shareholders can reinvest through the fund’s DRP at a 2.5% discount to the relevant ASX trading average.

Nelson Resources has lodged a Notice of Intent to collect up to 1,000 short tons of remnant mineralised material from the Orleans Mine in Nevada for bulk-scale metallurgical testing. The program could test whether laboratory recovery results translate to commercial-mill conditions, but remains subject to approval, bonding and the appointment of a third-party mill.